Analgesics (Pharmacies) - Namibia

Revenue in the Analgesics market is projected to reach US$2.75m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.87%, resulting in a market volume of US$3.48m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$1.04 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Namibia has been experiencing significant growth in recent years.

Customer preferences: Customers in Namibia have shown a growing preference for analgesics purchased from pharmacies. This is due to the trust and reliability associated with purchasing medication from a licensed pharmacy. Customers value the convenience of being able to consult with a pharmacist and receive professional advice on the appropriate analgesic for their specific needs. Additionally, customers appreciate the wide range of analgesic options available in pharmacies, allowing them to choose the product that best suits their preferences and requirements.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in Namibia is the increasing demand for over-the-counter (OTC) analgesics. This can be attributed to several factors. Firstly, the growing awareness and acceptance of self-medication among consumers has led to a higher demand for OTC analgesics. Consumers are becoming more knowledgeable about common ailments and are confident in their ability to choose and use analgesics without a prescription. Secondly, the affordability and accessibility of OTC analgesics have contributed to their popularity. These products are often priced lower than prescription analgesics and can be easily purchased from pharmacies without the need for a doctor's visit.

Local special circumstances: Namibia has a relatively small population compared to other countries, which has led to a concentrated market for analgesics. This means that the demand for analgesics is largely driven by the needs of the local population, rather than tourists or foreign visitors. The local market dynamics and preferences play a significant role in shaping the development of the Analgesics (Pharmacies) market in Namibia.

Underlying macroeconomic factors: The growth of the Analgesics (Pharmacies) market in Namibia can also be attributed to several underlying macroeconomic factors. Firstly, the overall economic development of the country has led to an increase in disposable income, allowing consumers to spend more on healthcare products, including analgesics. Secondly, the improving healthcare infrastructure in Namibia has contributed to the growth of the market. The availability of well-equipped pharmacies and a trained workforce of pharmacists has made it easier for consumers to access analgesics and receive professional advice. Lastly, the increasing urbanization and changing lifestyles in Namibia have resulted in a higher incidence of health issues, such as stress and musculoskeletal problems, leading to a greater demand for analgesics. In conclusion, the Analgesics (Pharmacies) market in Namibia is developing due to the preferences of customers for purchasing medication from pharmacies, the increasing demand for OTC analgesics, the unique local market circumstances, and the underlying macroeconomic factors.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.